• Quotes

  • NAVs

  • News

  • Messages

  • Opinions

  • Notices

  • Videos

Budget News Markets Mutual Funds IPO Commodities Wealth Portfolio Messages Mail CNBC-TV18
CNBC-TV18 Matrix SENSEX 17454.70 -123.53 NIFTY 5222.30 -40.50
 

Dishman Pharmaceuticals & Chemicals Nine Months, Dishman Pharmaceuticals & Chemicals Financial Statement & Accounts

Dishman Pharmaceuticals & Chemicals

BSE: 532526  |  NSE: DISHMAN  |  ISIN: INE353G01020  |  Pharmaceuticals

Print/Copy to Excel :
« Previous Years  

Nine Months of Dishman Pharmaceuticals & Chemicals

------------------- in Rs. Cr. -------------------
Dec '05 Dec '06 Dec '07 Dec '08 Dec '09
Sales Turnover 151.90 201.17 256.11 311.37 258.80
Other Income 7.75 9.92 9.22 -3.89 --
Total Income 159.65 211.09 265.33 307.49 258.80
Total Expenses 108.74 144.71 191.06 202.48 170.17
Operating Profit 43.16 56.46 65.05 108.89 88.63
Profit On Sale Of Assets -- -- -- -- --
Profit On Sale Of Investments -- -- -- -- --
Gain/Loss On Foreign Exchange -- -- -- -- --
VRS Adjustment -- -- -- -- --
Other Extraordinary Income/Expenses -- -- -- -- --
Total Extraordinary Income/Expenses -- -- -- -13.18 -0.54
Tax On Extraordinary Items -- -- -- -- --
Net Extra Ordinary Income/Expenses -- -- -- -- --
Gross Profit 50.91 66.38 74.27 105.00 88.63
Interest 2.63 3.01 5.28 12.21 13.58
PBDT 48.29 63.36 68.99 79.63 74.52
Depreciation 7.25 10.57 12.72 14.31 15.37
Depreciation On Revaluation Of Assets -- -- -- -- --
PBT 41.04 52.79 56.27 65.32 59.15
Tax 2.35 6.12 6.06 4.58 6.64
Net Profit 38.69 46.67 50.21 60.74 52.51
Prior Years Income/Expenses -- -- -0.01 -- --
Depreciation for Previous Years Written Back/ Provided -- -- -- -- --
Dividend -- -- -- -- --
Dividend Tax -- -- -- -- --
Dividend (%) -- -- -- -- --
Earnings Per Share 5.63 6.76 6.48 7.53 6.51
Book Value -- -- -- -- --
Equity 13.73 13.81 15.51 16.14 16.14
Reserves -- -- -- -- --
Face Value 2.00 2.00 2.00 2.00 2.00
Source : Religare Technova
Explore Dishman Pharma connections